-+ 0.00%
-+ 0.00%
-+ 0.00%

GeneDx names former Quest executive Mark Gardner as president

PUBT·06/16/2026 12:30:46
Listen to the news
GeneDx names former Quest executive Mark Gardner as president
  • GeneDx appointed Mark Gardner as president, effective June 15, 2026.
  • He will run commercial operations, aiming to tighten execution, scale the business, expand its position in genomic medicine.
  • Gardner previously led molecular genomics and oncology as senior vice president at Quest Diagnostics.
  • He was CEO of OmniSeq before its acquisition by Labcorp.
  • Earlier roles included senior leadership posts at Thermo Fisher Scientific, Life Technologies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606160830BIZWIRE_USPR_____20260616_BW791724) on June 16, 2026, and is solely responsible for the information contained therein.